Cohen Jacob D.
Mangoceuticals, Inc. · Chief Executive Officer
Cohen Jacob D. is listed in public filings as director, 10 percent owner, officer: Chief Executive Officer. This Cohen Jacob D. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Mangoceuticals, Inc. (MGRX). Investors use Cohen Jacob D.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $02M shares | OtherMar 16, 2026 | $4.6M2M shares | $2.30 | -- | |
| $900k2M shares | Grant / ExerciseMar 16, 2026 | $900.0K2M shares | $0.45 | -- | |
| $050k shares | OtherMar 16, 2026 | $825.0K50k shares | $16.50 | -- | |
| $083.3k shares | OtherMar 16, 2026 | $400.0K83.3k shares | $4.80 | -- | |
| $37k83.3k shares | Grant / ExerciseMar 16, 2026 | $37.5K83.3k shares | $0.45 | -- | |
| $23k50k shares | Grant / ExerciseMar 16, 2026 | $22.5K50k shares | $0.45 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $4.6M2M shares | Grant / ExerciseSep 9, 2025 | $4.6M2M shares | $2.30 | -- | |
| --500k shares | Grant / ExerciseSep 9, 2025 | Disclosure amount unavailable500k shares | -- | -- | |
| $0 | Grant / ExerciseJul 21, 2025 | Disclosure amount unavailable | $1.79 | -- | |
| $93k50k shares | Grant / ExerciseJul 21, 2025 | $92.5K50k shares | $1.85 | -- | |
| --200k shares | Grant / ExerciseJun 5, 2025 | Disclosure amount unavailable200k shares | -- | -- | |
| --200k shares | Grant / ExerciseApr 10, 2025 | Disclosure amount unavailable200k shares | -- | -- | |
| --800k shares | Grant / ExerciseAug 26, 2024 | Disclosure amount unavailable800k shares | -- | -- |